Antiangiogenic drugs in the management of ocular diseases: Focus on antivascular endothelial growth factor
Yukio Sassa, Yasuaki HataDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanAbstract: Age-related macular degeneration (AMD) complications are the leading cause of severe vision loss among the aging population in the many western countries. The introdu...
Guardado en:
Autores principales: | Yukio Sassa, Yasuaki Hata |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b76f7850d4434736b3bbd437ed9e89ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Use of antivascular endothelial growth factor for diabetic macular edema
por: Rushmia Karim, et al.
Publicado: (2010) -
Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy
por: Carreras A, et al.
Publicado: (2012) -
Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
por: Asahi MG, et al.
Publicado: (2017) -
Treatment of retinal pigment epithelial detachment with antiangiogenic therapy
por: Luis Arias
Publicado: (2010) -
Emerging roles for antiangiogenesis factors in management of ocular disease
por: Saeed MU, et al.
Publicado: (2013)